Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection?
Transpl Infect Dis
; 12(6): 561-4, 2010 Dec.
Article
in En
| MEDLINE
| ID: mdl-21040283
ABSTRACT
Organisms contained in probiotics are generally regarded as non-pathogenic and safe to administer. However, increasing reports of probiotic-associated infection raise concern over the safety of these products. We report a case of Lactobacillus empyema in a human immunodeficiency virus-infected lung transplant recipient receiving a probiotic containing Lactobacillus rhamnosus GG. We compare the epidemiology of Lactobacillus infections in heart and lung transplant recipients at our institution before and after the introduction of this probiotic, and discuss the potential mechanism for Lactobacillus within the probiotic to cause infections and disseminate.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heart Transplantation
/
Lung Transplantation
/
Gram-Positive Bacterial Infections
/
Empyema, Pleural
/
Probiotics
/
Lacticaseibacillus rhamnosus
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Transpl Infect Dis
Journal subject:
TRANSPLANTE
Year:
2010
Document type:
Article
Affiliation country:
United States